Month: June 2023

Epsilon Energy Ltd. Announces Quarterly Dividend

Written by Customer Service on June 7, 2023. Posted in Dividend Reports And Estimates.

HOUSTON, June 07, 2023 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that its Board of Directors has declared a dividend of $0.0625 per share of common stock (annualized $0.25/sh) to the stock holders of record at the close of business on June 15th 2023, payable on June 30th 2023. All dividends paid by the Company are “eligible dividends” as defined in subsection 89(1) of the Income Tax Act (Canada), unless indicated otherwise. About Epsilon Epsilon Energy Ltd. is a North American onshore natural gas production and midstream company with assets in Pennsylvania, Texas, New Mexico, and Oklahoma. Contact Information: 281-670-0002 Jason StabellChief Executive OfficerJason.Stabell@EpsilonEnergyLTD.com Andrew Williamson Chief Financial Officer Andrew.Williamson@EpsilonEnergyLTD.c...

Adjournment of Lone Star Bank Special Meeting of Shareholders Until July 11, 2023

Written by Customer Service on June 7, 2023. Posted in Mergers And Acquisitions.

HOUSTON, June 07, 2023 (GLOBE NEWSWIRE) — First Guaranty Bancshares, Inc. (Nasdaq: FGBI) (“First Guaranty”) previously filed a proxy statement/prospectus with respect to a special meeting of the shareholders of Lone Star Bank (“Lone Star”) to be held on Tuesday, June 13, 2023 at 10:00 a.m., local time, at the Hilton Houston Westchase, 9999 Westheimer Rd., Houston, Texas 77042 (the “Special Meeting”) to, among other things, vote on a proposal to approve the Agreement and Plan of Merger, dated January 6, 2023 (the “Merger Agreement”), by and among First Guaranty, First Guaranty Bank, a Louisiana state bank and First Guaranty’s wholly-owned banking subsidiary, and Lone Star, pursuant to which Lone Star will merge with and into First Guaranty Bank, with First Guaranty Bank surviving the merger (the “Merger”), and the transactions contemplated...

Merit Medical Announces New Five-Year Senior Secured Credit Agreement

Written by Customer Service on June 7, 2023. Posted in Public Companies.

Credit agreement includes a revolving credit facility of up to $700 million and a term loan facility of up to $150 million SOUTH JORDAN, Utah, June 07, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that it has entered into a new, five-year senior secured credit agreement. The credit agreement includes a revolving credit facility in an aggregate principal amount of up to $700 million and a term loan facility in an aggregate principal amount of up to $150 million. Wells Fargo Bank, National Association is acting as administrative agent for a group of financial institutions providing the new credit facilities. Merit has borrowed approximately $242 million under the new credit facilities and intends to use the proceeds for general...

4DMT Presents Positive Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial in Patients with Cystic Fibrosis at the ECFS 46th Annual Meeting

Written by Customer Service on June 7, 2023. Posted in Public Companies.

4D-710 Clinical Activity & Biomarker Summary for Cohort 1 (n=3) Phase 1 Dose Exploration Cohort 1 Interim Clinical Activity Data: Table 1Reported data from cohort 1 (n=3, 1E15 vg dose) of cystic fibrosis modulator treatment ineligible/intolerant participants with 9-12 months follow-upQuality of life outcomes measured by Cystic Fibrosis Questionnaire-Revised respiratory symptom score (CFQ-R-R) meaningfully improved for all three participantsPercent predicted forced expiratory volume in one second (ppFEV1) meaningfully improved in participant with moderate ppFEV1 impairment at baseline; ppFEV1 maintained stable in participants with normal or mild impairment at baselineBronchoscopy sample results demonstrated widespread and consistent expression of the cystic fibrosis transmembrane conductance regulator (CFTR) transgene...

GENFIT Announces New Data at the European Association for the Study of the Liver (EASL) Congress 2023

Written by Customer Service on June 7, 2023. Posted in Public Companies.

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); June 7, 2023 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced that it will present new data at the EASL Congress which will take place on June 21-24, 2023 in Vienna, Austria. Posters and Presentations GENFIT has had three abstracts accepted for poster sessions. Presentations include preclinical data showing the beneficial effects of nitazoxanide (NTZ) in an Acute-on-Chronic Liver Failure (ACLF) disease model, NIS2+™ as an effective screening tool for optimizing patient selection in clinical trials targeting at-risk Non-Alcoholic Steatohepatitis (NASH) and NIS2+™ as the most adapted Non-Invasive Test (NIT) for an efficient...

Akoya Biosciences Announces Public Offering of Common Stock

Written by Customer Service on June 7, 2023. Posted in Public Companies.

MARLBOROUGH, Mass., June 07, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced it has launched an underwritten public offering of shares of its common stock (the “Offering”). In addition, Akoya expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Akoya intends to use the net proceeds from the Offering for working capital and general corporate purposes. Morgan Stanley and Piper Sandler, are acting as joint book-running managers for the Offering. The securities described above are being offered by Akoya pursuant to a shelf...

American Pacific Mining Announces Michael Gentile Increases Ownership to 12.48%

Written by Customer Service on June 7, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, June 07, 2023 (GLOBE NEWSWIRE) — American Pacific Mining Corp (CSE: USGD / FWB: 1QC / OTCQX: USGDF) (“APM” or the “Company”) is pleased to announce that Michael Gentile has exercised a total of 8,181,964 common share purchase warrants (each a “Warrant”) at $0.16 per common share (each a “Share”) for total proceeds of $1,309,114.24 received by the Company. Following the Warrant exercise, Mr. Gentile holds 22,552,932 Shares and 2,236,974 Warrants, representing 11.48% of the issued and outstanding Shares of the Company on a non-diluted basis, and, on a partially diluted basis, (i.e., assuming full exercise of the Warrants), Mr. Gentile would hold a total of 24,789,906 Shares, representing approximately 12.48% of the Company’s issued and outstanding Shares. The Company also announces that it intends to...

Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports First-Quarter Results

Written by Customer Service on June 7, 2023. Posted in Dividend Reports And Estimates.

First quarter sales grew 19%, with sales growth in each operating group Gross margin expanded 130 basis points to 65.5% on a GAAP basis and 65.8% on an adjusted basis First quarter GAAP EPS of $3.64 and adjusted EPS of $3.78ATLANTA, June 07, 2023 (GLOBE NEWSWIRE) — Oxford Industries, Inc. (NYSE:OXM) today announced financial results for its fiscal 2023 first quarter ended April 29, 2023. Consolidated net sales in the first quarter of fiscal 2023 increased 19% to $420 million compared to $353 million in the first quarter of fiscal 2022. EPS on a GAAP basis increased to $3.64 compared to $3.45 in the first quarter of fiscal 2022. On an adjusted basis, EPS increased to $3.78 compared to $3.50 in the first quarter of fiscal 2022. Tom Chubb, Chairman and CEO, commented, “Our strong brands, exceptional products, aspirational messaging...

BBS-Bioactive Bone Substitutes Plc: 57% of warrants 2-2022 (TO2) used for the subscription of shares, company raises EUR 162,000 in gross proceeds

Written by Customer Service on June 7, 2023. Posted in Public Companies.

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 7 June 2023 at 10.30 p.m. EEST BBS-Bioactive Bone Substitutes Plc: 57% of warrants 2-2022 (TO2) used for the subscription of shares, company raises EUR 162,000 in gross proceeds. The subscription period for BBS-Bioactive Bone Substitutes Plc’s (“BBS” or “Company”) first series of warrants 2-2022 (TO2) ended on 2 June 2023. In total, 254 580 warrants 2-2022 (TO2) were used, corresponding to approximately 57.2 percent of the total number of warrants. BBS received approximately EUR 162,000 in gross proceeds before expenses. The company’s Board of Directors has today approved the share subscriptions. The subscription price was EUR 0.65 and SEK 7.38 per share. The subscription period for the shares was 22 May – 2 June 2023. The shares are expected to be registered in the...

Inventiva announces five scientific presentations at the EASL International Liver Congress™ 2023

Written by Customer Service on June 7, 2023. Posted in Public Companies.

Five poster presentations showing :the correlation between the improvement of hepatic steatosis and a robust increase in adiponectin levels, improvement in lipid profile and glycemic control in patients with non-cirrhotic NASH treated with lanifibranor. the Early improvement in ALT or AST being predictive of response pattern of liver histology as well as non-invasive hepatic and cardiometabolic biomarkers observed after 24-week treatment with lanifibranor in patients with non-cirrhotic NASH. the improvement of portal hypertension and splanchnic circulation independently of fibrosis reduction and metabolic improvement following lanifibranor treatment in a mouse model of prehepatic portal hypertension. the reduction of the increased portal pressure and improvement of steatosis in a rat model of early NAFLD following a 4-week lanifibranor...

Month: June 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals